These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11700160)

  • 21. Major depression, C-reactive protein, and incident ischemic heart disease in healthy men and women.
    Surtees PG; Wainwright NW; Boekholdt SM; Luben RN; Wareham NJ; Khaw KT
    Psychosom Med; 2008 Oct; 70(8):850-5. PubMed ID: 18725428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Québec Cardiovascular Study.
    St-Pierre AC; Cantin B; Dagenais GR; Mauriège P; Bernard PM; Després JP; Lamarche B
    Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):553-9. PubMed ID: 15618542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osteoprotegerin improves risk detection by traditional cardiovascular risk factors and hsCRP.
    Mogelvang R; Haahr-Pedersen S; Bjerre M; Frystyk J; Iversen A; Galatius S; Flyvbjerg A; Jensen JS
    Heart; 2013 Jan; 99(2):106-10. PubMed ID: 23135978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neopterin predicts the risk for fatal ischemic heart disease in type 2 diabetes mellitus: long-term follow-up of the HUNT 1 study.
    Vengen IT; Dale AC; Wiseth R; Midthjell K; Videm V
    Atherosclerosis; 2009 Nov; 207(1):239-44. PubMed ID: 19409566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women.
    Everett BM; Kurth T; Buring JE; Ridker PM
    J Am Coll Cardiol; 2006 Dec; 48(11):2235-42. PubMed ID: 17161253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C-reactive protein levels are not associated with increased risk for colorectal cancer in women.
    Zhang SM; Buring JE; Lee IM; Cook NR; Ridker PM
    Ann Intern Med; 2005 Mar; 142(6):425-32. PubMed ID: 15767620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular risk prediction in the general population with use of suPAR, CRP, and Framingham Risk Score.
    Lyngbæk S; Marott JL; Sehestedt T; Hansen TW; Olsen MH; Andersen O; Linneberg A; Haugaard SB; Eugen-Olsen J; Hansen PR; Jeppesen J
    Int J Cardiol; 2013 Sep; 167(6):2904-11. PubMed ID: 22909410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998.
    Thorand B; Löwel H; Schneider A; Kolb H; Meisinger C; Fröhlich M; Koenig W
    Arch Intern Med; 2003 Jan; 163(1):93-9. PubMed ID: 12523922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triglycerides and HDL-cholesterol as risk factors for ischemic heart disease. Results from the Québec cardiovascular study.
    Lamarche B; Després JP; Moorjani S; Cantin B; Dagenais GR; Lupien PJ
    Atherosclerosis; 1996 Jan; 119(2):235-45. PubMed ID: 8808500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leptinemia is not a risk factor for ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study.
    Couillard C; Lamarche B; Mauriège P; Cantin B; Dagenais GR; Moorjani S; Lupien PJ; Després JP
    Diabetes Care; 1998 May; 21(5):782-6. PubMed ID: 9589240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study.
    Wilson PW; Nam BH; Pencina M; D'Agostino RB; Benjamin EJ; O'Donnell CJ
    Arch Intern Med; 2005 Nov; 165(21):2473-8. PubMed ID: 16314543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association between C-reactive protein levels and the risk for chronic kidney disease hospitalizations in adults of a remote Indigenous Australian community - A prospective cohort study.
    Arnold LW; Hoy WE; Wang Z
    Nephrology (Carlton); 2017 Sep; 22(9):699-705. PubMed ID: 27312245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma free fatty acid levels and the risk of ischemic heart disease in men: prospective results from the Québec Cardiovascular Study.
    Pirro M; Mauriège P; Tchernof A; Cantin B; Dagenais GR; Després JP; Lamarche B
    Atherosclerosis; 2002 Feb; 160(2):377-84. PubMed ID: 11849661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-sensitivity C-reactive protein in the prediction of coronary events in patients with premature coronary artery disease.
    Speidl WS; Graf S; Hornykewycz S; Nikfardjam M; Niessner A; Zorn G; Wojta J; Huber K
    Am Heart J; 2002 Sep; 144(3):449-55. PubMed ID: 12228781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease.
    Ridker PM; Stampfer MJ; Rifai N
    JAMA; 2001 May; 285(19):2481-5. PubMed ID: 11368701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein-B, low-density lipoprotein cholesterol, and the long-term risk of coronary heart disease in men.
    St-Pierre AC; Cantin B; Dagenais GR; Després JP; Lamarche B
    Am J Cardiol; 2006 Apr; 97(7):997-1001. PubMed ID: 16563904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and incident coronary heart disease: the PRIME Study.
    Luc G; Arveiler D; Evans A; Amouyel P; Ferrieres J; Bard JM; Elkhalil L; Fruchart JC; Ducimetiere P;
    Atherosclerosis; 2003 Sep; 170(1):169-76. PubMed ID: 12957696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C-reactive protein and endovascular treatment of lower limb peripheral artery disease: an independent prognostic factor.
    Bleda S; de Haro J; Varela C; Acin F
    J Endovasc Ther; 2015 Apr; 22(2):233-9. PubMed ID: 25809368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognosis by C-reactive protein and matrix metalloproteinase-9 levels in stable coronary heart disease during 15 years of follow-up.
    Eldrup N; Kragelund C; Steffensen R; Nordestgaard BG
    Nutr Metab Cardiovasc Dis; 2012 Aug; 22(8):677-83. PubMed ID: 21194909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma homocysteine predicts progression of atherosclerosis.
    Rasouli ML; Nasir K; Blumenthal RS; Park R; Aziz DC; Budoff MJ
    Atherosclerosis; 2005 Jul; 181(1):159-65. PubMed ID: 15939068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.